Unlocking novel therapeutic targets: a synergy of cutting-edge science and data harmonization
BioTechX 2023 presentation
ONTOFORCE’s Vice President of Sales & Partnerships, Carl Latham, had the opportunity to present with James Longden, Head of Discovery Biology at e-therapeutics on driving data innovation to accelerate target identification during the 2023 BioTechX Europe conference in Basel.
HepNet™ is e-therapeutics’s proprietary, hepatocyte-specific, computational biology platform that addresses key limitations of the biopharmaceutical industry, including extracting value from big data, addressing complex diseases, and improving translatability in R&D.
HepNet™ is a combination of unstructured data, structured data (through the knowledge graph), and proprietary network analytics. HepNet™’s knowledge graph is built by leveraging ONTOFORCE’s DISQOVER.
Watch the recording
Talk to one of our experts and see DISQOVER in action
